• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK BIOTECH BIODESIGN ANTERIOR PELVIC FLOOR GRAFT; PELVIC FLOOR ANTERIOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK BIOTECH BIODESIGN ANTERIOR PELVIC FLOOR GRAFT; PELVIC FLOOR ANTERIOR Back to Search Results
Catalog Number J-PF-ANT-SSL
Device Problem Insufficient Information (3190)
Patient Problems Pain (1994); Injury (2348)
Event Type  Injury  
Event Description
The pt was reportedly implanted with a biodesign surgisis vaginal erosion repair graft and a boston scientific solyx system on (b)(6) 2011, an unspecified surgisis graft and a bard ajust on (b)(6) 2012, and a biodesign surgisis anterior pelvic floor graft on (b)(6) 2013.The pt and her attorney have alleged that as a result of these products being placed in the pt, the pt has experienced pain, injury, and has undergone corrective surgery.The following info was not provided by the complainant: specific info of the alleged injury; specific info regarding whether intervention was performed; specific info regarding why intervention was performed or what type/to what extent intervention was performed; specific correlation between device performance and alleged injury; current pt status.
 
Manufacturer Narrative
Conclusion: root cause inconclusive.This mdr is related to mdr 1835959-2014-00011 and mdr 1835959-2014-00012.A review of medical records indicated that on (b)(6) 2011, the pt underwent a diagnostic hysteroscopy with anterior colporrhaphy using surgisis and placement of a transobturator tape with solyx, performed by dr.(b)(6) at (b)(6) hospital, for treatment of her mixed urinary incontinence and cystocele.An (b)(6) 2011 two week post-operative appointment indicated, the pt had tremendous improvement in her urinary incontinence but she still experienced urinary urgency.A (b)(6) 2011 appointment indicated that at the pt's 6 week post-operative appointment, she was started on medication for help with her mixed incontinence.There was discussion of the pt's coughing episodes causing increased intra-abdominal pressure likely being the cause of her recurrent incontinence.The pt had a urodynamics study on (b)(6) 2012 which was negative.The pt had office visits on (b)(6) 2012 and (b)(6) 2012 for re-eval of her urinary incontinence.On (b)(6) 2012, the pt expressed concern over her vaginal bleeding and pressure from her uterus.On (b)(6) 2012, the pt underwent a vaginal hysterectomy with anterior colporrhaphy, sacrospinous ligament fixation, and placement of transobturator tape with cystoscopy, performed by dr.(b)(6) at (b)(6) hospital, for the treatment of her menorrhagia, uterine prolapse, cystocele, and mixed urinary incontinence.No documents were available for 2013.Investigation - eval: investigation into this claim included a review of the claim allegations, a review of the cbi complaint system, a review of the device history records which indicated the product was manufactured to specifications, a review of the biodesign surgisis anterior pelvic floor graft ifu fp0040-01d and other communication and investigation into this report/claim is being handled by our attorney.Summary of investigation findings: no details were provided relating to the (b)(6) 2013 surgery.After reviewing the details received, it does not appear that the biodesign surgisis anterior pelvic floor graft caused or contributed to any life threatening illness or injury, permanent impairment or damage, nor did the pt require medical or surgical intervention to preclude serious injury or death as a result o the graft being placed.The pt did not experience any symptoms as a result of the biodesign surgisis anterior pelvic floor graft being placed that should they recur would be likely to cause or contribute to death, serious injury, or require medical or surgical intervention to preclude serious injury or death.Based on the info provided by the complainant, details regarding a specific correction between the biodesign surgisis anterior pelvic floor graft's performance and the alleged injury remain unk.A root cause of the claim allegations is inconclusive.All other matters relating to this litigation are being handled by our attorney.If/when additional info is obtained a follow-up mdr will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIODESIGN ANTERIOR PELVIC FLOOR GRAFT
Type of Device
PELVIC FLOOR ANTERIOR
Manufacturer (Section D)
COOK BIOTECH
west lafayette IN 47906
Manufacturer Contact
perry guinn, vp
1425 innovation place
west lafayette, IN 47906
7654973355
MDR Report Key3675113
MDR Text Key21488793
Report Number1835959-2014-00013
Device Sequence Number1
Product Code PAI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Attorney
Type of Report Initial
Report Date 02/26/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2014
Device Catalogue NumberJ-PF-ANT-SSL
Device Lot NumberLB630830
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/29/2014
Initial Date FDA Received02/26/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/17/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BOSTON SCIENTIFIC SOLYX SYSTEM LOT # 1ML0110103; BARD AJUST LOT # HUWF 1501
Patient Outcome(s) Disability;
-
-